| Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis M Liao, Y Li, F Kianifard, E Obi, S Arcona BMC nephrology 17, 1-14, 2016 | 125 | 2016 |
| Asthma control and disease burden in patients with asthma and allergic comorbidities LK Lee, E Obi, B Paknis, A Kavati, B Chipps Journal of Asthma 55 (2), 208-219, 2018 | 86 | 2018 |
| Health care costs for patients with heart failure escalate nearly 3-fold in final months of life EN Obi, JP Swindle, SJ Turner, PA Russo, A Altan Journal of managed care & specialty pharmacy 22 (12), 1446-1456, 2016 | 23 | 2016 |
| Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States Y Jiang, EM Sarpong, P Sears, EN Obi Infectious Diseases and Therapy, 1-16, 2021 | 15 | 2021 |
| Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life RL Hengel, CP Schroeder, J Jo, TE Ritter, RV Nathan, AJ Gonzales-Luna, ... Journal of Patient-Reported Outcomes 6 (1), 49, 2022 | 9 | 2022 |
| Healthcare costs among patients with heart failure: a comparison of costs between matched decedent and survivor cohorts EN Obi, JP Swindle, SJ Turner, PA Russo, A Altan Advances in therapy 34, 261-276, 2017 | 9 | 2017 |
| Risk assessment of post-discharge mortality among recently hospitalized Medicare heart failure patients with reduced or preserved ejection fraction M Stampehl, HS Friedman, P Navaratnam, P Russo, S Park, EN Obi Current Medical Research and Opinion 36 (2), 179-188, 2020 | 8 | 2020 |
| Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study E Bouza, J Cobo, MJ Rodríguez-Hernández, M Salavert, JP Horcajada, ... Revista Española de Quimioterapia 34 (2), 126, 2021 | 6 | 2021 |
| Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failure AB Hauber, EN Obi, MA Price, D Whalley, CL Chang Current Medical Research and Opinion 33 (11), 2027-2038, 2017 | 6 | 2017 |
| Clinical and economic outcomes after implementation of a fidaxomicin treatment optimization and access pathway at a US hospital system LF McDaniel, MN White, EN Obi, RM Kohinke, ERS Lockhart, ... Infectious Diseases and Therapy 12 (1), 95-107, 2023 | 4 | 2023 |
| Crowdsourcing healthcare technology innovation: the use of open competitions to pursue novel healthcare technology solutions JJ Ko, TS Karagiannis, M Tran, EN Obi Value in Health 18 (3), A101, 2015 | 4 | 2015 |
| Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer DMA Francisco, L Zhang, Y Jiang, A Olvera, J Adachi, EY Guevara, ... Infectious Diseases and Therapy 12 (1), 209-225, 2023 | 3 | 2023 |
| 379. A budget impact analysis of bezlotoxumab for the management of recurrent Clostridioides difficile infection in the United States Y Jiang, A Deshpande, Q Li, L Siegartel, F Siddiqui, EN Obi Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 457, 2022 | 3 | 2022 |
| Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction AF Mohanty, EB Levitan, JB King, JA Dodson, O Vardeny, J Cook, ... Journal of the American Heart Association 10 (20), e020474, 2021 | 3 | 2021 |
| Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013. BC Stuart, SE Tom, M Choi, A Johnson, K Sun, D Qato, EN Obi, C Zacker, ... The American journal of managed care 24 (6), e175-e182, 2018 | 3 | 2018 |
| The long-term therapy with low-dose aspirin did not reduce cardiovascular events in patients with type 2 diabetes in primary prevention setting: 10-year follow-up of a … Y Saito, S Okada, H Ogawa, H Soejima, M Sakuma, M Nakayama, N Dohi, ... Circulation 134 (suppl_1), A13428-A13428, 2016 | 3 | 2016 |
| Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received … TP Lodise, E Yucel, EN Obi, AH Watanabe, BH Nathanson Journal of Antimicrobial Chemotherapy 79 (1), 82-95, 2024 | 2 | 2024 |
| Effectiveness of ertapenem for treatment of infections in children: an evidence mapping and meta-analysis R Zhao, X Long, J Wang, J Zhu, C Liu, T Shang, Z Zhang, E Obi, ... Frontiers in Pediatrics 10, 982179, 2022 | 2 | 2022 |
| 673. Study of prescribing patterns and effectiveness of ceftolozane/tazobactam real-world analysis (SPECTRA): results from a multi-national, multicenter observational study A Soriano, LA Puzniak, D Paterson, F Thalhammer, S Kluge, P Viale, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 725, 2022 | 1 | 2022 |
| Adoption and Trends in Uptake of Updated ICD-10 Codes for Clostridioides difficile—A Retrospective Observational Study A Deshpande, Y Chen, E Boye-Codjoe, EN Obi Open Forum Infectious Diseases 9 (12), ofac622, 2022 | 1 | 2022 |
Abhishek KavatiNovartis在 novartis.com 的电子邮件经过验证
